Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

128

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
20/26/20	€0.1546	+0.39%	5,11,475
19/26/19	€0.1540	+0.79%	75,301
18/26/18	€0.1528	+0.13%	67,869
17/26/17	€0.1526	-1.93%	2,12,520
14/26/14	€0.1556	0.00%	3,22,844

Real-time Euronext Paris

More quotes

Annual profits - Rate of surprise

Company calendar

Market Closed - Euronext Paris 09:25:00 20/08/2026 pm IST			Pre-market 10:43:56 am
0.1546 ^EUR	+0.39%		0.1590	+2.85%

11/08	Klea Holding SA Reports Unaudited Consolidated Sales Results for the first half of 2026	CI
29/07	EQT to sell Quantios to Vista Equity Partners	FW

Market Cap	4.75Cr 5.54Cr 4.43Cr 4.06Cr 7.64Cr 530.39Cr 7.79Cr 53Cr 20Cr 265.81Cr 21Cr 20Cr 880.01Cr	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	4.76Cr 5.56Cr 4.44Cr 4.07Cr 7.66Cr 531.79Cr 7.81Cr 53Cr 21Cr 266.51Cr 21Cr 20Cr 882.33Cr	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

11/08	Klea Holding SA Reports Unaudited Consolidated Sales Results for the first half of 2026	CI
29/07	EQT to sell Quantios to Vista Equity Partners	FW
15/07	Klea Holding targets improved profitability in the second half
11/06	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
11/06	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
11/06	Klea Holding announces the launch of its new subsidiary
23/04	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01/04	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
01/04	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
19/01	Klea Holding Increases Annual Revenue by 28%
19/01	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
19/01	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
27/25/27	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI

15/07	Klea : Smart Salem records a strong rebound in activity in June 2026, confirms solid profitability and favourable outlook	PU
15/07	Klea Holding : Smart Salem records a strong rebound in activity in June 2026, confirms solid profitability and favourable outlook	AT
11/06	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
23/04	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
23/04	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT

Klea Holding Share Price

Stocks

ALKLH

FR0013481835

Healthcare Facilities & Services

Valuation: Klea Holding

Chart: Klea Holding

Latest news : Klea Holding

Analysts' recommendations: Klea Holding

Press Releases: Klea Holding

News in other languages: Klea Holding

Quotes and Performance

Course Extremes

Managers and Directors: Klea Holding

Latest insider transactions

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

17/08	Klea : Déclaration des transactions sur actions propres
17/08	Klea Holding : Déclaration des transactions sur actions propres
27/07	Klea Holding : Déclaration des transactions sur actions propres
20/07	Klea Holding : Déclaration des transactions sur actions propres
15/07	Klea Holding vise une amélioration de sa rentabilité au second semestre

1 day	+0.39%
1 week	-0.64%
Current month	-1.02%
1 month	-3.50%
3 months	-20.31%
6 months	-32.78%
Current year	-29.41%

1 week	0.15	0.16
1 month	0.15	0.16
Current year	0.15	0.25
1 year	0.15	0.31
3 years	0.15	0.44
5 years	0.08	0.59
10 years	0.08	149.6

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	22/01/2024
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	01/04/2022

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	01/04/2022
Paul Amsellem BRD	Director/Board Member	51	14/06/2023

Date	Insider	Type	Quantity	% Market Cap.
17/07/26	Raphael Smila	Buy	1,03,000	0.0335%
17/07/26	Raphael Smila	Buy	1,03,000	0.0335%
16/07/26	Raphael Smila	Buy	87,000	0.0283%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLEA HOLDING	+0.39%	-0.64%	-24.03%	-52.43%	5.54Cr
CVS HEALTH CORPORATION	0.00%	-1.41%	+32.24%	+40.17%	12TCr
HCA HEALTHCARE, INC.	-0.19%	-1.33%	-0.95%	+51.01%	8.8TCr
QUEST DIAGNOSTICS INCORPORATED	-0.19%	+2.23%	+30.86%	+80.75%	2.66TCr
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-0.25%	+4.12%	-3.88%	-9.17%	2.22TCr
TENET HEALTHCARE CORPORATION	+1.52%	+2.08%	+49.83%	+285.68%	2.19TCr
REDE D'OR SÃO LUIZ S.A.	+0.30%	-2.29%	-9.61%	+13.48%	1.42TCr
FRESENIUS MEDICAL CARE AG	-0.10%	-0.24%	-5.59%	-8.26%	1.27TCr
DAVITA INC.	-1.15%	-2.19%	+27.52%	+72.55%	1.12TCr
PT SEJAHTERARAYA ANUGRAHJAYA TBK	-3.53%	+10.38%	+131.45%	+2,074.24%	988.18Cr
Average	-0.44%	+1.06%	+22.78%	+254.80%	3.26TCr
Weighted average by Cap.	-0.17%	-0.15%	+21.46%	+119.19%

	2024	2025
Net sales	1.73Cr 2.02Cr 1.61Cr 1.48Cr 2.78Cr 192.89Cr 2.83Cr 19Cr 7.45Cr 97Cr 7.57Cr 7.4Cr 320.04Cr	2.22Cr 2.59Cr 2.07Cr 1.9Cr 3.57Cr 247.72Cr 3.64Cr 25Cr 9.56Cr 124.15Cr 9.72Cr 9.51Cr 411Cr
Net income	14.05L 16.41L 13.11L 12.03L 22.6L 16Cr 23.05L 1.56Cr 60.62L 7.87Cr 61.62L 60.27L 26Cr	22.81L 26.64L 21.28L 19.53L 36.7L 25Cr 37.42L 2.52Cr 98.42L 13Cr 1Cr 97.85L 42Cr
Net Debt	25.75L 30.07L 24.03L 22.05L 41.42L 29Cr 42.24L 2.85Cr 1.11Cr 14Cr 1.13Cr 1.1Cr 48Cr	1L 1L 1L 1L 2L 1.4Cr 2L 13.84L 5L 70.01L 5L 5L 2.32Cr